Chantalat, E., Valera, C., Vaysse, C., Noirrit, E., Rusidze, M., Weyl, A., Vergriete, K., Buscail, E., Lluel, P., Fontaine, C., Arnal, F., & Lenfant, F
GHRP-2 adds somatostatin suppression, which produces larger absolute pulse amplitudes but also compresses the natural trough the pulsatile signal becomes somewhat more continuous under repeated GHRP-2 administration
The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone
Doses above 3 mg per day lack additional evidence of benefit and are not generally recommended
Sequence libraries were constructed using the TruSeq DNA Sample Prep Kit (Illumina, San Diego, USA)
The majority of these peptides currently exist in a gray zone where they are legal to purchase and own but are not approved for human use